Annual FCF
-$7.24 M
-$3.36 M-86.79%
December 31, 2023
Summary
- As of February 8, 2025, COEP annual free cash flow is -$7.24 million, with the most recent change of -$3.36 million (-86.79%) on December 31, 2023.
- During the last 3 years, COEP annual FCF has fallen by -$4.10 million (-130.84%).
- COEP annual FCF is now -130.84% below its all-time high of -$3.14 million, reached on December 1, 2020.
Performance
COEP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.89 M
-$474.90 K-33.50%
September 1, 2024
Summary
- As of February 8, 2025, COEP quarterly free cash flow is -$1.89 million, with the most recent change of -$474.90 thousand (-33.50%) on September 1, 2024.
- Over the past year, COEP quarterly FCF has dropped by -$198.80 thousand (-11.74%).
- COEP quarterly FCF is now -166.52% below its all-time high of $2.85 million, reached on December 1, 2021.
Performance
COEP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$6.91 M
+$65.80 K+0.94%
September 1, 2024
Summary
- As of February 8, 2025, COEP TTM free cash flow is -$6.91 million, with the most recent change of +$65.80 thousand (+0.94%) on September 1, 2024.
- Over the past year, COEP TTM FCF has increased by +$333.10 thousand (+4.60%).
- COEP TTM FCF is now -3671.98% below its all-time high of -$183.10 thousand, reached on September 30, 2022.
Performance
COEP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
COEP Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -86.8% | -11.7% | +4.6% |
| 3 y3 years | -130.8% | -83.1% | -0.8% |
| 5 y5 years | -130.8% | -83.1% | -0.8% |
COEP Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.8% | at low | -166.5% | +3.4% | -3672.0% | +7.4% |
| 5 y | 5-year | -130.8% | at low | -166.5% | +75.4% | -3672.0% | +24.0% |
| alltime | all time | -130.8% | at low | -166.5% | +75.4% | -3672.0% | +24.0% |
Coeptis Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.89 M(+33.5%) | -$6.91 M(-0.9%) |
| Jun 2024 | - | -$1.42 M(-25.5%) | -$6.97 M(-6.5%) |
| Mar 2024 | - | -$1.90 M(+12.3%) | -$7.46 M(+3.0%) |
| Dec 2023 | -$7.24 M(+86.8%) | -$1.69 M(-13.5%) | -$7.24 M(+13.2%) |
| Sep 2023 | - | -$1.96 M(+2.9%) | -$6.39 M(+16.9%) |
| Jun 2023 | - | -$1.90 M(+13.0%) | -$5.47 M(+18.9%) |
| Mar 2023 | - | -$1.68 M(+98.8%) | -$4.60 M(+18.6%) |
| Dec 2022 | -$3.88 M | -$847.40 K(-18.0%) | -$3.88 M(+2016.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$1.03 M(-0.0%) | -$183.10 K(-97.3%) |
| Jun 2022 | - | -$1.03 M(+7.5%) | -$6.85 M(+4.7%) |
| Mar 2022 | - | -$961.70 K(-133.8%) | -$6.55 M(+4.9%) |
| Dec 2021 | -$6.24 M(+99.0%) | - | - |
| Dec 2021 | - | $2.85 M(-136.9%) | -$6.24 M(-31.3%) |
| Sep 2021 | - | -$7.70 M(+962.5%) | -$9.08 M(+558.1%) |
| Jun 2021 | - | -$725.10 K(+10.7%) | -$1.38 M(+110.7%) |
| Mar 2021 | - | -$655.30 K | -$655.30 K |
| Dec 2020 | -$3.14 M | - | - |
FAQ
- What is Coeptis Therapeutics annual free cash flow?
- What is the all time high annual FCF for Coeptis Therapeutics?
- What is Coeptis Therapeutics annual FCF year-on-year change?
- What is Coeptis Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Coeptis Therapeutics?
- What is Coeptis Therapeutics quarterly FCF year-on-year change?
- What is Coeptis Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Coeptis Therapeutics?
- What is Coeptis Therapeutics TTM FCF year-on-year change?
What is Coeptis Therapeutics annual free cash flow?
The current annual FCF of COEP is -$7.24 M
What is the all time high annual FCF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high annual free cash flow is -$3.14 M
What is Coeptis Therapeutics annual FCF year-on-year change?
Over the past year, COEP annual free cash flow has changed by -$3.36 M (-86.79%)
What is Coeptis Therapeutics quarterly free cash flow?
The current quarterly FCF of COEP is -$1.89 M
What is the all time high quarterly FCF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high quarterly free cash flow is $2.85 M
What is Coeptis Therapeutics quarterly FCF year-on-year change?
Over the past year, COEP quarterly free cash flow has changed by -$198.80 K (-11.74%)
What is Coeptis Therapeutics TTM free cash flow?
The current TTM FCF of COEP is -$6.91 M
What is the all time high TTM FCF for Coeptis Therapeutics?
Coeptis Therapeutics all-time high TTM free cash flow is -$183.10 K
What is Coeptis Therapeutics TTM FCF year-on-year change?
Over the past year, COEP TTM free cash flow has changed by +$333.10 K (+4.60%)